Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Bone Grafts and Substitutes Pipeline Market Report Overview

Bone grafts and substitutes are used in surgical procedures of bones in the human body. It is used in two cases either when there is a breakage in the bone or in the case of a void between or in the bones due to several factors such as age and degenerative diseases. Bone graft substitutes are synthetic substances that are an alternative to bone allografts and autografts. Allograft Bone Chips, Bone Morphogenetic Proteins (BMP), Demineralized Bone Matrix (DBM), synthetic bone substitutes, and cell-based matrices are covered under this segment.

The applications in the segment are based on the division of the entire skeleton structure into Trauma for fractures;-CMF for craniomaxillofacial (excluding the dental market which is covered within a different market); spinal fusions (since all spinal fusions will need some amount of bone graft usage), and joint reconstruction and replacements (including repairs) for large joints which includes hip and knee, and other joints which include shoulder, elbow, wrist, digit, and ankle.

The bone grafts and substitutes pipeline market research report provides comprehensive information about the bone grafts and substitutes pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments Synthetic Bone Graft Substitutes, Bone Morphogenetic Proteins (BMP), Demineralized Bone Matrix (DBM), Demineralized Bone Matrix (DBM) – Putty, Cell-Based Matrices, and Allograft Bone Chips
Key Territories The US, Europe, China, Japan, and Taiwan
Key Regulatory Paths 510(k), PMA, CE, NMPA, TGA, Ninsho, and De Novo
Leading Companies Arthro Kinetics AG, Arugula Sciences LLC, Aursos, Inc (Inactive), Baxter International Inc, BellaSeno GmbH, Berkeley Advanced Biomaterials Inc, and Bio2 Technologies Inc

Bone Grafts and Substitutes Pipeline Market Segments

Some of the key segments in the bone grafts and substitutes pipeline market are synthetic bone graft substitutes, bone morphogenetic proteins (BMP), demineralized bone matrix (DBM) demineralized bone matrix (DBM) – putty, cell-based matrices,  and allograft bone chips. As of May 2023, synthetic bone graft substitutes have the highest number of pipeline products.

Bone Grafts and Substitutes Pipeline Market Analysis, by Segments, 2023 (%)

Bone Grafts and Substitutes Pipeline Market Analysis, by Segments, 2023 (%)

For more segments insights into the bone grafts and substitutes pipeline market, download a free report sample

Bone Grafts and Substitutes Pipeline Market Segmentation by Territories

Some of the territories in the bone grafts and substitute pipeline market are the US, Europe, China, Japan, and Taiwan among others. As of May 2023, the US has the highest number of pipeline products.

Bone Grafts and Substitutes Pipeline Market Analysis, by Territories, 2023 (%)

Bone Grafts and Substitutes Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the bone grafts and substitutes pipeline market, download a free report sample

Bone Grafts and Substitutes Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the bone grafts and substitute pipeline market are 510(k), PMA, CE, NMPA, TGA, Ninsho, and De Novo among others. As of May 2023, 510(k) is the most followed pathway for pipeline products.

Bone Grafts and Substitutes Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Bone Grafts and Substitutes Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the bone grafts and substitutes pipeline market, download a free report sample

Bone Grafts and Substitutes Pipeline Market – Competitive Landscape

Some of the key companies in the bone grafts and substitute pipeline market are Arthro Kinetics AG, Arugula Sciences LLC, Aursos, Inc (Inactive), Baxter International Inc, BellaSeno GmbH, Berkeley Advanced Biomaterials Inc, and Bio2 Technologies Inc among others.

Arthro Kinetics AG: Arthro Kinetics AG (Arthro Kinetics), formerly Arthro Kinetics Plc is a medical device company that researches, develops, manufactures, and markets biological implants. The company’s biological implants are used for the treatment of the human musculoskeletal system. Arthro Kinetics undertakes research and development in the biological treatment of osteoarthritis, articular cartilage in the hip, joint. Arthro Kinetics’ cartilage regeneration system is a patented collagen type I matrix colonized with autologous cartilage cells used for the regeneration of articular cartilage defects. The company also offers an implant for the reconstruction of the nucleus in the treatment of herniated discs to restore the natural shock-absorbing capacity of the disc. It has a cooperation agreement with companies located in Iran, Turkey, China, and Japan. Arthro Kinetics is headquartered in Tubingen, Baden-Wurttemberg, Germany.

Segments Covered in the Report

Bone Grafts and Substitutes Pipeline Market Segments Outlook

  • Synthetic Bone Graft Substitutes
  • Bone Morphogenetic Proteins (BMP)
  • Demineralized Bone Matrix (DBM)
  • Demineralized Bone Matrix (DBM) – Putty
  • Cell-Based Matrices
  • Allograft Bone Chips

Bone Grafts and Substitutes Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Japan
  • Australia
  • Taiwan

Bone Grafts and Substitutes Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • PMA
  • CE
  • NMPA
  • TGA
  • Ninsho
  • De Novo

Scope

  • Extensive coverage of the bone grafts and substitutes under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of bone grafts and substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of bone grafts and substitutes under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Acro Biomedical Co Ltd
Acuitive Technologies Inc
Adocia SAS
Aesculap Biologics LLC
Agenta Biotechnologies Inc (Inactive)
Amend Surgical, Inc.
Anika Therapeutics Inc
Antibe Therapeutics Inc
Aperion Biologics Corp
Arthro Kinetics AG
Arugula Sciences LLC
Aursos, Inc (Inactive)
Baxter International Inc
BellaSeno GmbH
Berkeley Advanced Biomaterials Inc
Bio2 Technologies Inc
Bioactive Bone Substitutes Plc
BioGend Therapeutics Co Ltd
Biomatlante SA
Bioregeneration Technologies, Inc
Biorez Inc
Bio-Scaffold International Pte Ltd
Bioventus Inc
BonAlive Biomaterials Ltd.
Bone Biologics Corp
Bone Solutions Inc
BoneGrafix, Inc.
BoneSupport AB
Bonus BioGroup Ltd
Calcitec, Inc.
Carmell Therapeutics Corp
Case Western Reserve University
Cellumed Co Ltd
CeraPedics Inc
Citrics Biomedical, LLC (Inactive)
Collagen Solutions Ltd
Collplant Biotechnologies Ltd
Daewoong Pharmaceutical Co Ltd
Department of Biomedical Engineering Columbia University
Dimension Inx LLC
Drexel University
DSM Biomedical BV
Element Orthopedics Inc (Inactive)
Elute Inc
ElutInc
Ember Therapeutics Inc
EpiBone Inc
Eskisehir Osmangazi University
EternoGen Aesthetics LLC
Exactech Inc
Ferring Pharmaceuticals AS
Fuse Medical Inc
Gene Biotherapeutics Inc
Graftoss Limited
Graftys SA
Hangzhou Huamai Medical Equipment Co Ltd
Hospital for Special Surgery
Indian Institute of Technology Bombay
Induce Biologics Inc.
Industrie Biomediche Insubri SA
Innovoss Inc. (Inactive)
IRCCS San Raffaele Hospital
Isto Biologics
Johns Hopkins University
kasios sas
King's College London
Kuros Biosciences AG
Lattice Biologics Ltd
Locate Bio Ltd
Maxigen Biotech Inc
Medisse BV (Inactive)
Medtronic Plc
MEGA Bio Pharma
Miromatrix Medical Inc
N2 Biomedical
NanoFUSE Biologics LLC
National Center of Innovation for Biomaterials in Orthopaedic Research
National University of Science and Technology MiSiS
Nutech Medical Inc
NuVasive Inc
Orthocell Ltd
OrthoMedex LLC
Orthosera GmbH
OssiFi Inc
OsteoNovus, LLC
Osteopore International Pte Ltd
Particle3D
PolyPid Ltd
Polytechnic University of Catalonia
Promimic AB
ReCaPP
RepRegen Ltd. (Inactive)
Revivicor Inc
Richard L. Roudebush VAMC
ROKIT Healthcare Inc
Sanara MedTech Inc
Scil Technology GmbH
SDIP Innovations Pty Ltd
SeaSpine, Inc.
Serigen Mediproducts Pvt Ltd
SIRAKOSS Ltd
Smith & Nephew Inc
Sofregen Medical Inc
Soteira Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
STEL Technologies LLC
SurgaColl Technologies Ltd
Surgalign Holdings Inc
SurGenTec LLC
T&R Biofab Co Ltd
TBF Genie Tissulaire
The Chinese University of Hong Kong
Theragnostic Technologies Inc
Tissue Regeneration Systems, Inc.
Trinity College Dublin
University of California San Diego
University of Edinburgh
University of Malaya
University of Maryland
University of Massachusetts Amherst
University of Memphis
University of Missouri
University of Pecs
University of South Florida
UNSW Medicine
Vanderbilt University
Vivex Biologics Inc
Wayne State University
Wright Medical Group NV (Inactive)
Xtant Medical Holdings Inc

Table of Contents

1 Table of Contents 3

1.1 List of Tables 11

1.2 List of Figures 22

2 Introduction 23

2.1 Bone Grafts and Substitutes Overview 23

3 Products under Development 24

3.1 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 24

3.2 Bone Grafts and Substitutes – Pipeline Products by Segment 25

3.3 Bone Grafts and Substitutes – Pipeline Products by Territory 26

3.4 Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 27

3.5 Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 28

3.6 Bone Grafts and Substitutes – Ongoing Clinical Trials 29

4 Bone Grafts and Substitutes – Pipeline Products under Development by Companies 30

4.1 Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 30

4.2 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 35

5 Bone Grafts and Substitutes Companies and Product Overview 40

5.1 Acro Biomedical Co Ltd Company Overview 40

5.1.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.2 Acuitive Technologies Inc Company Overview 41

5.2.1 Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.3 Adocia SAS Company Overview 42

5.3.1 Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview 42

5.4 Aesculap Biologics LLC Company Overview 45

5.4.1 Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 45

5.5 Agenta Biotechnologies Inc (Inactive) Company Overview 46

5.5.1 Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

5.6 Amend Surgical, Inc. Company Overview 47

5.6.1 Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.7 Anika Therapeutics Inc Company Overview 48

5.7.1 Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.8 Antibe Therapeutics Inc Company Overview 50

5.8.1 Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.9 Aperion Biologics Corp Company Overview 52

5.9.1 Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 52

5.10 Arthro Kinetics AG Company Overview 55

5.10.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 55

5.11 Arugula Sciences LLC Company Overview 56

5.11.1 Arugula Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 56

5.12 Aursos, Inc (Inactive) Company Overview 59

5.12.1 Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59

5.13 Baxter International Inc Company Overview 60

5.13.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.14 BellaSeno GmbH Company Overview 61

5.14.1 BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 61

5.15 Berkeley Advanced Biomaterials Inc Company Overview 62

5.15.1 Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 62

5.16 Bio2 Technologies Inc Company Overview 64

5.16.1 Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.17 Bioactive Bone Substitutes Plc Company Overview 67

5.17.1 Bioactive Bone Substitutes Plc Pipeline Products & Ongoing Clinical Trials Overview 67

5.18 BioGend Therapeutics Co Ltd Company Overview 70

5.18.1 BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

5.19 Biomatlante SA Company Overview 75

5.19.1 Biomatlante SA Pipeline Products & Ongoing Clinical Trials Overview 75

5.20 Bioregeneration Technologies, Inc Company Overview 78

5.20.1 Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.21 Biorez Inc Company Overview 79

5.21.1 Biorez Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.22 Bio-Scaffold International Pte Ltd Company Overview 80

5.22.1 Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

5.23 Bioventus Inc Company Overview 83

5.23.1 Bioventus Inc Pipeline Products & Ongoing Clinical Trials Overview 83

5.24 BonAlive Biomaterials Ltd. Company Overview 84

5.24.1 BonAlive Biomaterials Ltd. Pipeline Products & Ongoing Clinical Trials Overview 84

5.25 Bone Biologics Corp Company Overview 85

5.25.1 Bone Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 85

5.26 Bone Solutions Inc Company Overview 90

5.26.1 Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.27 BoneGrafix, Inc. Company Overview 93

5.27.1 BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93

5.28 BoneSupport AB Company Overview 94

5.28.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 94

5.29 Bonus BioGroup Ltd Company Overview 101

5.29.1 Bonus BioGroup Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.30 Calcitec, Inc. Company Overview 106

5.30.1 Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106

5.31 Carmell Therapeutics Corp Company Overview 107

5.31.1 Carmell Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 107

5.32 Case Western Reserve University Company Overview 108

5.32.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 108

5.33 Cellumed Co Ltd Company Overview 109

5.33.1 Cellumed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109

5.34 CeraPedics Inc Company Overview 111

5.34.1 CeraPedics Inc Pipeline Products & Ongoing Clinical Trials Overview 111

5.35 Citrics Biomedical, LLC (Inactive) Company Overview 114

5.35.1 Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 114

5.36 Collagen Solutions Ltd Company Overview 115

5.36.1 Collagen Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

5.37 Collplant Biotechnologies Ltd Company Overview 116

5.37.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 116

5.38 Daewoong Pharmaceutical Co Ltd Company Overview 117

5.38.1 Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

5.39 Department of Biomedical Engineering Columbia University Company Overview 119

5.39.1 Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 119

5.40 Dimension Inx LLC Company Overview 120

5.40.1 Dimension Inx LLC Pipeline Products & Ongoing Clinical Trials Overview 120

5.41 Drexel University Company Overview 122

5.41.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 122

5.42 DSM Biomedical BV Company Overview 124

5.42.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 124

5.43 Element Orthopedics Inc (Inactive) Company Overview 125

5.43.1 Element Orthopedics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 125

5.44 Elute Inc Company Overview 126

5.44.1 Elute Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.45 ElutInc Company Overview 127

5.45.1 ElutInc Pipeline Products & Ongoing Clinical Trials Overview 127

5.46 Ember Therapeutics Inc Company Overview 129

5.46.1 Ember Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 129

5.47 EpiBone Inc Company Overview 130

5.47.1 EpiBone Inc Pipeline Products & Ongoing Clinical Trials Overview 130

5.48 Eskisehir Osmangazi University Company Overview 133

5.48.1 Eskisehir Osmangazi University Pipeline Products & Ongoing Clinical Trials Overview 133

5.49 EternoGen Aesthetics LLC Company Overview 134

5.49.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 134

5.50 Exactech Inc Company Overview 135

5.50.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 135

5.51 Ferring Pharmaceuticals AS Company Overview 136

5.51.1 Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview 136

5.52 Fuse Medical Inc Company Overview 139

5.52.1 Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.53 Gene Biotherapeutics Inc Company Overview 140

5.53.1 Gene Biotherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 140

5.54 Graftoss Limited Company Overview 141

5.54.1 Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview 141

5.55 Graftys SA Company Overview 142

5.55.1 Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 142

5.56 Hangzhou Huamai Medical Equipment Co Ltd Company Overview 145

5.56.1 Hangzhou Huamai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145

5.57 Hospital for Special Surgery Company Overview 148

5.57.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 148

5.58 Indian Institute of Technology Bombay Company Overview 149

5.58.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 149

5.59 Induce Biologics Inc. Company Overview 150

5.59.1 Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview 150

5.60 Industrie Biomediche Insubri SA Company Overview 151

5.60.1 Industrie Biomediche Insubri SA Pipeline Products & Ongoing Clinical Trials Overview 151

5.61 Innovoss Inc. (Inactive) Company Overview 152

5.61.1 Innovoss Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

5.62 IRCCS San Raffaele Hospital Company Overview 153

5.62.1 IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview 153

5.63 Isto Biologics Company Overview 154

5.63.1 Isto Biologics Pipeline Products & Ongoing Clinical Trials Overview 154

5.64 Johns Hopkins University Company Overview 155

5.64.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 155

5.65 kasios sas Company Overview 157

5.65.1 kasios sas Pipeline Products & Ongoing Clinical Trials Overview 157

5.66 King’s College London Company Overview 159

5.66.1 King’s College London Pipeline Products & Ongoing Clinical Trials Overview 159

5.67 Kuros Biosciences AG Company Overview 160

5.67.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 160

5.68 Lattice Biologics Ltd Company Overview 166

5.68.1 Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 166

5.69 Locate Bio Ltd Company Overview 168

5.69.1 Locate Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

5.70 Maxigen Biotech Inc Company Overview 171

5.70.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 171

5.71 Medisse BV (Inactive) Company Overview 173

5.71.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 173

5.72 Medtronic Plc Company Overview 174

5.72.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 174

5.73 MEGA Bio Pharma Company Overview 181

5.73.1 MEGA Bio Pharma Pipeline Products & Ongoing Clinical Trials Overview 181

5.74 Miromatrix Medical Inc Company Overview 182

5.74.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 182

5.75 N2 Biomedical Company Overview 183

5.75.1 N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 183

5.76 NanoFUSE Biologics LLC Company Overview 184

5.76.1 NanoFUSE Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 184

5.77 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 185

5.77.1 National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 185

5.78 National University of Science and Technology MiSiS Company Overview 186

5.78.1 National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 186

5.79 Nutech Medical Inc Company Overview 187

5.79.1 Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 187

5.80 NuVasive Inc Company Overview 188

5.80.1 NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview 188

5.81 Orthocell Ltd Company Overview 189

5.81.1 Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

5.82 OrthoMedex LLC Company Overview 191

5.82.1 OrthoMedex LLC Pipeline Products & Ongoing Clinical Trials Overview 191

5.83 Orthosera GmbH Company Overview 192

5.83.1 Orthosera GmbH Pipeline Products & Ongoing Clinical Trials Overview 192

5.84 OssiFi Inc Company Overview 193

5.84.1 OssiFi Inc Pipeline Products & Ongoing Clinical Trials Overview 193

5.85 OsteoNovus, LLC Company Overview 194

5.85.1 OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 194

5.86 Osteopore International Pte Ltd Company Overview 195

5.86.1 Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

5.87 Particle3D Company Overview 199

5.87.1 Particle3D Pipeline Products & Ongoing Clinical Trials Overview 199

5.88 PolyPid Ltd Company Overview 200

5.88.1 PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 200

5.89 Polytechnic University of Catalonia Company Overview 201

5.89.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 201

5.90 Promimic AB Company Overview 202

5.90.1 Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 202

5.91 ReCaPP Company Overview 203

5.91.1 ReCaPP Pipeline Products & Ongoing Clinical Trials Overview 203

5.92 RepRegen Ltd. (Inactive) Company Overview 204

5.92.1 RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 204

5.93 Revivicor Inc Company Overview 206

5.93.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 206

5.94 Richard L. Roudebush VAMC Company Overview 207

5.94.1 Richard L. Roudebush VAMC Pipeline Products & Ongoing Clinical Trials Overview 207

5.95 ROKIT Healthcare Inc Company Overview 208

5.95.1 ROKIT Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 208

5.96 Sanara MedTech Inc Company Overview 211

5.96.1 Sanara MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 211

5.97 Scil Technology GmbH Company Overview 212

5.97.1 Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 212

5.98 SDIP Innovations Pty Ltd Company Overview 213

5.98.1 SDIP Innovations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 213

5.99 SeaSpine, Inc. Company Overview 214

5.99.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214

5.100 Serigen Mediproducts Pvt Ltd Company Overview 215

5.100.1 Serigen Mediproducts Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 215

5.101 SIRAKOSS Ltd Company Overview 216

5.101.1 SIRAKOSS Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

5.102 Smith & Nephew Inc Company Overview 219

5.102.1 Smith & Nephew Inc Pipeline Products & Ongoing Clinical Trials Overview 219

5.103 Sofregen Medical Inc Company Overview 220

5.103.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 220

5.104 Soteira Inc Company Overview 222

5.104.1 Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview 222

5.105 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 223

5.105.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 223

5.106 STEL Technologies LLC Company Overview 224

5.106.1 STEL Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 224

5.107 SurgaColl Technologies Ltd Company Overview 225

5.107.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

5.108 Surgalign Holdings Inc Company Overview 226

5.108.1 Surgalign Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 226

5.109 SurGenTec LLC Company Overview 228

5.109.1 SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview 228

5.110 T&R Biofab Co Ltd Company Overview 229

5.110.1 T&R Biofab Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 229

5.111 TBF Genie Tissulaire Company Overview 230

5.111.1 TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview 230

5.112 The Chinese University of Hong Kong Company Overview 233

5.112.1 The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 233

5.113 Theragnostic Technologies Inc Company Overview 234

5.113.1 Theragnostic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 234

5.114 Tissue Regeneration Systems, Inc. Company Overview 235

5.114.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 235

5.115 Trinity College Dublin Company Overview 236

5.115.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 236

5.116 University of California San Diego Company Overview 237

5.116.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 237

5.117 University of Edinburgh Company Overview 238

5.117.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 238

5.118 University of Malaya Company Overview 239

5.118.1 University of Malaya Pipeline Products & Ongoing Clinical Trials Overview 239

5.119 University of Maryland Company Overview 240

5.119.1 University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 240

5.120 University of Massachusetts Amherst Company Overview 241

5.120.1 University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 241

5.121 University of Memphis Company Overview 242

5.121.1 University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 242

5.122 University of Missouri Company Overview 243

5.122.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 243

5.123 University of Pecs Company Overview 244

5.123.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 244

5.124 University of South Florida Company Overview 245

5.124.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 245

5.125 UNSW Medicine Company Overview 246

5.125.1 UNSW Medicine Pipeline Products & Ongoing Clinical Trials Overview 246

5.126 Vanderbilt University Company Overview 247

5.126.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 247

5.127 Vivex Biologics Inc Company Overview 248

5.127.1 Vivex Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 248

5.128 Wayne State University Company Overview 251

5.128.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 251

5.129 Wright Medical Group NV (Inactive) Company Overview 252

5.129.1 Wright Medical Group NV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 252

5.130 Xtant Medical Holdings Inc Company Overview 256

5.130.1 Xtant Medical Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 256

6 Bone Grafts and Substitutes- Recent Developments 259

6.1 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 259

6.2 May 08, 2023: Hoya announces consolidated financial results for the fiscal year ended March 31, 2023 259

6.3 May 04, 2023: NuVasive announces conference call and webcast of Q1 2023 results 259

6.4 May 03, 2023: Sanara MedTech announces Q1 earnings release and conference call dates 259

6.5 Apr 27, 2023: Xtant Medical to issue First Quarter 2023 financial results on May 4, 2023 260

6.6 Apr 26, 2023: Orthofix Medical schedules Q1 earnings release and conference call for May 9, 2023 260

6.7 Apr 26, 2023: Smith & Nephew announces Q1 2023 trading update 260

6.8 Apr 19, 2023: Anika to issue first quarter 2023 financial results on Tuesday, may 9, 2023 263

6.9 Apr 12, 2023: Medtronic has a layoff in California 263

6.10 Apr 06, 2023: Smith & Nephew Notice of First Quarter 2023 Trading Report 263

6.11 Mar 31, 2023: Bioventus announces Q4 and full-year 2022 financial results 263

6.12 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format 265

6.13 Mar 28, 2023: Stryker announces Annual Meeting of Shareholders 266

6.14 Mar 16, 2023: Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023 266

6.15 Mar 16, 2023: Geistlich announces the dramatic expansion of their allograft portfolio – vallos sets the pace for regeneration 266

6.16 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 267

6.17 Mar 09, 2023: Bioactive Bone Substitutes Notice to the Annual General Meeting 267

6.18 Mar 07, 2023: Xtant Medical Announces Fourth Quarter and Full Year 2022 Financial Results 268

6.19 Mar 06, 2023: Anika Reports Fourth Quarter and Year-End Fiscal 2022 Financial Results 269

6.20 Mar 06, 2023: Smith & Nephew Announces Annual Financial Report 2022 270

6.21 Mar 06, 2023: Smith & Nephew Notice of 2023 Annual General Meeting 270

6.22 Feb 22, 2023: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022 271

6.23 Feb 21, 2023: Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023 272

6.24 Feb 21, 2023: Smith & Nephew Announces Fourth Quarter and Full Year 2022 Results 272

6.25 Feb 21, 2023: Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023 273

6.26 Feb 14, 2023: Spineway Reports Full Year 2022 Earnings 273

6.27 Feb 10, 2023: Olympus Announces Consolidated Financial Results for the Third Quarter and Full-year Forecasts for Fiscal 2023 274

6.28 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results 274

6.29 Feb 09, 2023: Spinal Elements Appoints Ron Lloyd as President and Chief Executive Officer 277

6.30 Feb 09, 2023: Spineway announces 2022 annual results 277

6.31 Jan 31, 2023: Hoya Announces Fourth semi-annual financial statements 278

6.32 Jan 09, 2023: Orthofix Medical Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results 280

6.33 Jan 09, 2023: ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility 282

6.34 Dec 06, 2022: UAT Group subsidiary Ossifix Orthopedics completes initial surgeries using new allograft bone pin system 283

6.35 Dec 01, 2022: CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results 285

6.36 Nov 23, 2022: Medtronic Reports Quarterly Earnings 287

6.37 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 287

6.38 Nov 21, 2022: Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance 292

6.39 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 294

6.40 Nov 11, 2022: Olympus Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 294

6.41 Nov 11, 2022: Olympus Announces Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023 296

6.42 Nov 10, 2022: Surgalign aims to slash $30M from 2023 spending with planned layoffs 296

6.43 Nov 08, 2022: Anika Reports Third Quarter Fiscal 2022 Financial Results 296

6.44 Nov 07, 2022: NuVasive launches tube system and excavation micro for posterior spine surgery 298

6.45 Oct 27, 2022: Xtant Medical to Issue Third Quarter 2022 Financial Results on November 3, 2022 299

6.46 Oct 25, 2022: Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022 299

6.47 Oct 25, 2022: Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022 299

6.48 Oct 21, 2022: Olympus Announces Leadership Succession Plan 300

6.49 Oct 21, 2022: Olympus Corp Notice Concerning Changes of Representative Executive Officer and Management Team 300

6.50 Oct 19, 2022: Allosource Announces Dean Elliott as New President and CEO 300

6.51 Oct 11, 2022: Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting 301

6.52 Oct 11, 2022: Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results 302

6.53 Oct 10, 2022: ATEC Announces Select Preliminary Third Quarter 2022 Financial Results and Raises Guidance 303

6.54 Oct 06, 2022: Integra LifeSciences appoints Harvinder Singh as Executive Vice President, President Of Co.”s International Business 304

6.55 Oct 06, 2022: Integra LifeSciences Announces Key Executive Appointment 304

6.56 Oct 04, 2022: Exactech Names New Chief Financial Officer 304

6.57 Sep 30, 2022: SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022 305

6.58 Sep 28, 2022: PolyPid announces eligibility for European Medicines Agency centralized procedure for D-PLEX100 for the prevention of surgical site infections in abdominal surgery 306

6.59 Sep 26, 2022: Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event 306

6.60 Sep 20, 2022: Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum 307

6.61 Sep 14, 2022: Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference 307

6.62 Sep 12, 2022: NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting 307

6.63 Sep 07, 2022: Bone Therapeutics reports half year 2022 results 308

6.64 Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors 310

6.65 Sep 07, 2022: Medtronic to appear at September investor conferences 310

6.66 Sep 06, 2022: Sanara MedTech to Present at the Virtual MicroCap Leadership Summit 310

6.67 Aug 30, 2022: ATEC to Participate in Upcoming Investor Conferences 310

6.68 Aug 25, 2022: Collplant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results 310

6.69 Aug 25, 2022: BBS-Bioactive Bone Substitutes announce Half-Year Financial Report 1 January – 30 June 2022 (unaudited) 313

6.70 Aug 23, 2022: New Chief Financial Officer Appointment Strengthens Spineology’s Executive Leadership Team 315

6.71 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 315

6.72 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 318

6.73 Aug 16, 2022: Sanara MedTech Announces Second Quarter 2022 Results 321

6.74 Aug 15, 2022: Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update 322

6.75 Aug 12, 2022: Sintx Technologies Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 323

6.76 Aug 11, 2022: Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance 324

6.77 Aug 10, 2022: Biogennix Reports Record Quarter and Half-Year Sales 326

6.78 Aug 10, 2022: Olympus announces First Quarter Results 326

6.79 Aug 09, 2022: Olympus Corp. Announces Consolidated Financial Results for the Three Months of the Fiscal Year Ending March 31, 2023 327

6.80 Aug 09, 2022: Kuros Biosciences reports results for the first six months of 2022 329

6.81 Aug 08, 2022: BBS-Bioactive Bone Substitutes makes changes in Management Team 329

6.82 Aug 04, 2022: ATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance 330

6.83 Aug 03, 2022: Anika Reports Second Quarter Fiscal 2022 Financial Results 330

6.84 Aug 02, 2022: Allosource Announces President and CEO Retirement 333

6.85 Aug 02, 2022: Zimmer Biomet Announces Second Quarter 2022 Financial Results 334

6.86 Aug 01, 2022: Miromatrix to Report Second Quarter 2022 Financial Results 334

6.87 Jul 28, 2022: Smith+Nephew Second Quarter and First Half 2022 Results 335

6.88 Jul 28, 2022: Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022 336

6.89 Jul 28, 2022: Balfour Beatty teams up with Steps to Hope to raise funds for people in need 336

6.90 Jul 26, 2022: ATEC to Participate in Upcoming Investor Conferences 337

6.91 Jul 21, 2022: ATEC to Report Second Quarter 2022 Financial Results on August 4 2022 337

6.92 Jul 18, 2022: AutoZone VP of communications and public affairs appointed to U of M Board of Trustees 337

6.93 Jul 12, 2022: Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 338

6.94 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue 338

6.95 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 338

6.96 Jun 27, 2022: Novel patching material for bone defects 339

6.97 Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference 340

6.98 Jun 09, 2022: Athersys Postpones Annual Meeting of Stockholders 340

6.99 Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors 340

6.100 Jun 03, 2022: Orthocell receives A$2.1m R&D tax incentive refund 341

6.101 Jun 02, 2022: Athersys Announces Restructuring and Management Changes to Focus on Its Existing Clinical Programs 341

6.102 Jun 01, 2022: Bone Therapeutics Provides First Quarter 2022 Business Update 341

6.103 May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes 342

6.104 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 344

6.105 May 26, 2022: CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results 344

6.106 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 346

6.107 May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference 346

6.108 May 25, 2022: ATEC to Host Investor Day, May 25, 2022 346

6.109 May 25, 2022: Miromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference 347

7 Appendix 348

7.1 Methodology 348

7.2 About GlobalData 351

7.3 Contact Us 351

7.4 Disclaimer 351

Table

Bone Grafts and Substitutes – Pipeline Products by Stage of Development 24

Bone Grafts and Substitutes – Pipeline Products by Segment 25

Bone Grafts and Substitutes – Pipeline Products by Territory 26

Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 27

Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 28

Bone Grafts and Substitutes – Ongoing Clinical Trials 29

Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 30

Bone Grafts and Substitutes – Pipeline Products by Stage of Development 35

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Acrobone – Product Status 40

Acrobone – Product Description 40

Acuitive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Citrefoam – Product Status 41

Citrefoam – Product Description 41

Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview 42

BioChaperone BMP – Degenerative Disc Disease – Product Status 42

BioChaperone BMP – Degenerative Disc Disease – Product Description 42

Biochaperone BMP – Non-Union Fractures – Product Status 43

Biochaperone BMP – Non-Union Fractures – Product Description 43

BioChaperone BMP – Osteoporosis – Product Status 43

BioChaperone BMP – Osteoporosis – Product Description 44

Aesculap Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 45

NOVOCART DISC basic – Product Status 45

NOVOCART DISC basic – Product Description 45

Agenta Biotechnologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

B-247 Cranial Bone Graft Implant – Product Status 46

B-247 Cranial Bone Graft Implant – Product Description 46

Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Biomimetic Bone – Product Status 47

Biomimetic Bone – Product Description 47

Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Hyalobone – Product Status 48

Hyalobone – Product Description 48

Hyalograft C Autograft – Product Status 49

Hyalograft C Autograft – Product Description 49

Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 50

CGX-227 – Product Status 50

CGX-227 – Product Description 50

CGX-443 – Product Status 51

CGX-443 – Product Description 51

Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 52

Z-Fix – Product Status 52

Z-Fix – Product Description 52

Z-Meniscus – Product Status 53

Z-Meniscus – Product Description 53

Z-Patch – Product Status 53

Z-Patch – Product Description 54

Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 55

CaReS plus – Product Status 55

CaReS plus – Product Description 55

Arugula Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview 56

Signature Cord Prime – Product Status 56

Signature Cord Prime – Product Description 56

Arugula Sciences LLC – Ongoing Clinical Trials Overview 57

Signature Cord Prime – A Phase I, Open-label, Dose-ranging Study to Assess the Safety, Tolerability, Preliminary Efficacy, and Dose Effect of Signature Cord Product in Patients with Symptomatic Osteoarthritis of the Knee 58

Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59

AUR-84 Resorbable Implant – Product Status 59

AUR-84 Resorbable Implant – Product Description 59

Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Synthetic Bone Graft – Spinal – Product Status 60

Synthetic Bone Graft – Spinal – Product Description 60

BellaSeno GmbH Pipeline Products & Ongoing Clinical Trials Overview 61

PCL Bone Scaffold Graft Cage – Product Status 61

PCL Bone Scaffold Graft Cage – Product Description 61

Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 62

CPA Ceramics – Product Status 62

CPA Ceramics – Product Description 62

HAP Ceramics – Product Status 63

HAP Ceramics – Product Description 63

Bio2 Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 64

Vitrium – Hammertoe Correction – Product Status 64

Vitrium – Hammertoe Correction – Product Description 64

Vitrium – Radial Osteotomy – Product Status 65

Vitrium – Radial Osteotomy – Product Description 65

Vitrium – Wrist Fracture Revision – Product Status 65

Vitrium – Wrist Fracture Revision – Product Description 66

Bioactive Bone Substitutes Plc Pipeline Products & Ongoing Clinical Trials Overview 67

Artebone – Product Status 67

Artebone – Product Description 68

Bone Graft Substitute – Blocks – Product Status 68

Bone Graft Substitute – Blocks – Product Description 68

Bone Graft Substitute – Granules – Product Status 69

Bone Graft Substitute – Granules – Product Description 69

BioGend Therapeutics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

OIF – Non-Union Bone Fracture – Product Status 70

OIF – Non-Union Bone Fracture – Product Description 70

OIF/ß-TCP – Block Form – Product Status 71

OIF/ß-TCP – Block Form – Product Description 71

OIF/ß-TCP – Granular Form – Product Status 71

OIF/ß-TCP – Granular Form – Product Description 72

BioGend Therapeutics Co Ltd – Ongoing Clinical Trials Overview 73

OIF/ß-TCP – Granular Form – A Randomized, Evaluator-blinded, Controlled Study to Evaluate the Safety and Clinical Performance of OIF/ß-TCP in Patients with Open Tibial Fractures in Need of Bone Grafting 74

Biomatlante SA Pipeline Products & Ongoing Clinical Trials Overview 75

Biological Graft – Product Status 75

Biological Graft – Product Description 75

Hydrogel – Product Status 76

Hydrogel – Product Description 76

Osteoconductive Resorbable Composite – Product Status 76

Osteoconductive Resorbable Composite – Product Description 77

Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 78

InMotion – Product Status 78

InMotion – Product Description 78

Biorez Inc Pipeline Products & Ongoing Clinical Trials Overview 79

L-C Ligament – Product Status 79

L-C Ligament – Product Description 79

Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 80

BMP And Growth Factor Loaded Scaffold – Orthodontic Oral/Maxillofacial Surgery – Product Status 80

BMP And Growth Factor Loaded Scaffold – Orthodontic Oral/Maxillofacial Surgery – Product Description 80

BMP And Growth Factor Loaded Scaffold – Orthopaedic Surgery – Product Status 81

BMP And Growth Factor Loaded Scaffold – Orthopaedic Surgery – Product Description 81

BMP And Growth Factor Loaded Scaffold – Plastic/Reconstructive Surgery – Product Status 81

BMP And Growth Factor Loaded Scaffold – Plastic/Reconstructive Surgery – Product Description 82

Bioventus Inc Pipeline Products & Ongoing Clinical Trials Overview 83

Bone Allograft – Spine And Trauma Surgery – Product Status 83

Bone Allograft – Spine And Trauma Surgery – Product Description 83

BonAlive Biomaterials Ltd. Pipeline Products & Ongoing Clinical Trials Overview 84

S53P4 BonAlive Granules – Product Status 84

S53P4 BonAlive Granules – Product Description 84

Bone Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 85

NB1 Bone Graft – Product Status 85

NB1 Bone Graft – Product Description 86

NELL-1/DBX Fusion Device – Osteoporosis – Product Status 86

NELL-1/DBX Fusion Device – Osteoporosis – Product Description 86

NELL-1/DBX Fusion Device – Trauma – Product Status 87

NELL-1/DBX Fusion Device – Trauma – Product Description 87

Bone Biologics Corp – Ongoing Clinical Trials Overview 88

NB1 Bone Graft – A Multi-center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety and Preliminary Effectiveness of NB1 Bone Graft in Subjects with Degenerative Disc Disease Undergoing Transforaminal Lumbar Interbody Fusion 89

Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Osteocrete – Bone Anchor – Product Status 90

Osteocrete – Bone Anchor – Product Description 90

OsteoCrete – Cranial – Product Status 91

OsteoCrete – Cranial – Product Description 91

OsteoCrete – Maxillofacial – Product Status 91

OsteoCrete – Maxillofacial – Product Description 92

OsteoCrete – Non Load Bearing Spine – Product Status 92

OsteoCrete – Non Load Bearing Spine – Product Description 92

BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 93

Solid Bone Block – Product Status 93

Solid Bone Block – Product Description 93

BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 94

Cerament + Bisphosphonate – Product Status 94

Cerament + Bisphosphonate – Product Description 94

Cerament + Bisphosphonates And BMP – Product Status 95

Cerament + Bisphosphonates And BMP – Product Description 95

Cerament + BMP – Product Status 95

Cerament + BMP – Product Description 96

Cerament + BMP 2 – Product Status 96

Cerament + BMP 2 – Product Description 96

Cerament Plus BMP And Stem Cells – Product Status 96

Cerament Plus BMP And Stem Cells – Product Description 97

Cerament|G – Product Status 97

Cerament|G – Product Description 97

Gelatin/Cerament – Product Status 98

Gelatin/Cerament – Product Description 98

BoneSupport AB – Ongoing Clinical Trials Overview 99

Cerament|G – Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones: Randomized Multicentre Study in the CRIOAc Network – CONVICTION Study 100

Cerament|G – Two-stage Treatment of Large Bone Defects with Cerament G and Cerament V plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy after Bone Resection in Patients with Septic Pseudarthrosis 100

Bonus BioGroup Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

BonoFill – Maxillofacial Application – Product Status 101

BonoFill – Maxillofacial Application – Product Description 101

BonoFill – Orthopedic Application – Product Status 102

BonoFill – Orthopedic Application – Product Description 102

Combined Bone And Cartilage Graft – Product Status 102

Combined Bone And Cartilage Graft – Product Description 102

Large Vascularized Bone Graft – Product Status 103

Large Vascularized Bone Graft – Product Description 103

Bonus BioGroup Ltd – Ongoing Clinical Trials Overview 104

BonoFill – Maxillofacial Application – Phase I/II Open Label First in Human Single Center Clinical Study Aimed to Evaluate the Safety and Efficacy of BonoFill-II in Reconstructing Maxillofacial Bone 105

Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106

Corticell – Product Status 106

Corticell – Product Description 106

Carmell Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 107

Bone Healing Accelerant – DBM Spine – Product Status 107

Bone Healing Accelerant – DBM Spine – Product Description 107

Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 108

Articular Cartilage – Joint Repairs – Product Status 108

Articular Cartilage – Joint Repairs – Product Description 108

Cellumed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109

Porcine Xenograft – Product Status 109

Porcine Xenograft – Product Description 109

Porous PVA Cartilage Graft – Product Status 110

Porous PVA Cartilage Graft – Product Description 110

CeraPedics Inc Pipeline Products & Ongoing Clinical Trials Overview 111

i-FACTOR+ Matrix Peptide Enhanced Bone Graft – Product Status 111

i-FACTOR+ Matrix Peptide Enhanced Bone Graft – Product Description 111

CeraPedics Inc – Ongoing Clinical Trials Overview 112

i-FACTOR+ Matrix Peptide Enhanced Bone Graft – An Assessment of P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion with Instrumentation 113

i-FACTOR+ Matrix Peptide Enhanced Bone Graft – Safety, Radiological and Patient Reported Outcomes of i-FACTOR+ Matrix Bone Graft Device – A Canadian, Multicenter, Post-Market Clinical Investigation 113

Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 114

CitrOSponge – Product Status 114

CitrOSponge – Product Description 114

Collagen Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

Bone Graft Substitutes – Product Status 115

Bone Graft Substitutes – Product Description 115

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 116

3D Bioprinted Bone Scaffold – Product Status 116

3D Bioprinted Bone Scaffold – Product Description 116

Daewoong Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 117

Bongros HA – Product Status 117

Bongros HA – Product Description 117

NOVOSIS – Spinal Fusion – Product Status 118

NOVOSIS – Spinal Fusion – Product Description 118

Department of Biomedical Engineering Columbia University Pipeline Products & Ongoing Clinical Trials Overview 119

Rotator Cuff Repair Graft – Product Status 119

Rotator Cuff Repair Graft – Product Description 119

Dimension Inx LLC Pipeline Products & Ongoing Clinical Trials Overview 120

3D-Printed Scaffold – Spinal Fusion – Product Status 120

3D-Printed Scaffold – Spinal Fusion – Product Description 120

Hyperelastic Bone – Product Status 121

Hyperelastic Bone – Product Description 121

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 122

3-D Scaffold – Product Status 122

3-D Scaffold – Product Description 122

Muscle-Polymer Constructs – Product Status 123

Muscle-Polymer Constructs – Product Description 123

DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 124

Structural Synthetic Bone Graft – Product Status 124

Structural Synthetic Bone Graft – Product Description 124

Element Orthopedics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 125

Beads-On-A-String Spinal Implant – Product Status 125

Beads-On-A-String Spinal Implant – Product Description 125

Elute Inc Pipeline Products & Ongoing Clinical Trials Overview 126

EP Granules With Tobramycin – Product Status 126

EP Granules With Tobramycin – Product Description 126

ElutInc Pipeline Products & Ongoing Clinical Trials Overview 127

ElutiBone – Product Status 127

ElutiBone – Product Description 127

ElutiBone – Product Status 128

ElutiBone – Product Description 128

Ember Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 129

BMP-7 – Osteoarthritis – Product Status 129

BMP-7 – Osteoarthritis – Product Description 129

EpiBone Inc Pipeline Products & Ongoing Clinical Trials Overview 130

EpiBone-CMF – Product Status 130

EpiBone-CMF – Product Description 130

EpiBone Inc – Ongoing Clinical Trials Overview 131

EpiBone-CMF – An Open-label, First-in-human, Single Intervention Study for Evaluation of EpiBone-CMF Engineered Living Bone Graft for Mandibular Ramus Reconstruction 132

Eskisehir Osmangazi University Pipeline Products & Ongoing Clinical Trials Overview 133

Antimicrobial Synthetic Bone Graft – Product Status 133

Antimicrobial Synthetic Bone Graft – Product Description 133

EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 134

Collagen Scaffold – Orthopedic Procedures – Product Status 134

Collagen Scaffold – Orthopedic Procedures – Product Description 134

Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 135

Cartilage Allograft – Product Status 135

Cartilage Allograft – Product Description 135

Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview 136

AMPLEX Osteo-Promotive Bone Graft System – Cervical Spine Fusion – Product Status 136

AMPLEX Osteo-Promotive Bone Graft System – Cervical Spine Fusion – Product Description 136

AMPLEX Osteo-Promotive Bone Graft System – Foot & Ankle Fusion – Product Status 137

AMPLEX Osteo-Promotive Bone Graft System – Foot & Ankle Fusion – Product Description 137

AMPLEX Osteo-Promotive Bone Graft System – Lumbar Spine Fusion – Product Status 137

AMPLEX Osteo-Promotive Bone Graft System – Lumbar Spine Fusion – Product Description 138

Fuse Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 139

FusePure Demineralized Bone Matrix – Product Status 139

FusePure Demineralized Bone Matrix – Product Description 139

Gene Biotherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 140

Osteorate – Product Status 140

Osteorate – Product Description 140

Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview 141

Bone Matrix – Product Status 141

Bone Matrix – Product Description 141

Graftys SA Pipeline Products & Ongoing Clinical Trials Overview 142

GRFT-M04 – Product Status 142

GRFT-M04 – Product Description 142

GRFT-R02 – Product Status 143

GRFT-R02 – Product Description 143

Injectable Resorbable Material – Product Status 143

Injectable Resorbable Material – Product Description 143

Intelligent Bone Substitute – Infection – Product Status 144

Intelligent Bone Substitute – Infection – Product Description 144

Intelligent Bone Substitute – Post-Operative Intraosseous Pain – Product Status 144

Intelligent Bone Substitute – Post-Operative Intraosseous Pain – Product Description 144

Hangzhou Huamai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 145

Injectable Bone Filler – Product Status 145

Injectable Bone Filler – Product Description 145

Hangzhou Huamai Medical Equipment Co Ltd – Ongoing Clinical Trials Overview 146

Injectable Bone Filler – A Randomized Controlled Clinical Investigation on Bone Repair Materials in the Treatment of Bone Defects in Extremities 147

Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview 148

Biological Spine Fusion Device – Product Status 148

Biological Spine Fusion Device – Product Description 148

Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 149

3-D Scaffold Matrix – Product Status 149

3-D Scaffold Matrix – Product Description 149

Induce Biologics Inc. Pipeline Products & Ongoing Clinical Trials Overview 150

Urist – Product Status 150

Urist – Product Description 150

Industrie Biomediche Insubri SA Pipeline Products & Ongoing Clinical Trials Overview 151

SmartBonePep – Product Status 151

SmartBonePep – Product Description 151

Innovoss Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 152

Synthetic Bone Material – Product Status 152

Synthetic Bone Material – Product Description 152

IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview 153

Tissue Repair Composite Scaffold – Product Status 153

Tissue Repair Composite Scaffold – Product Description 153

Isto Biologics Pipeline Products & Ongoing Clinical Trials Overview 154

InQu Bone Graft Extender And Substitute – Chondral Defects – Product Status 154

InQu Bone Graft Extender And Substitute – Chondral Defects – Product Description 154

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 155

Bone Graft Substitute – Spinal Fusion – Product Status 155

Bone Graft Substitute – Spinal Fusion – Product Description 155

Next Generation Hydrogel Implant – Product Status 156

Next Generation Hydrogel Implant – Product Description 156

kasios sas Pipeline Products & Ongoing Clinical Trials Overview 157

Next-Generation Spinal Fusion Device – Product Status 157

Next-Generation Spinal Fusion Device – Product Description 157

Spinal Fusion Device – Product Status 158

Spinal Fusion Device – Product Description 158

King’s College London Pipeline Products & Ongoing Clinical Trials Overview 159

Synthetic Bone Composite – Product Status 159

Synthetic Bone Composite – Product Description 159

Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 160

KUR – 111 – Product Status 160

KUR – 111 – Product Description 161

KUR – 112 – Product Status 161

KUR – 112 – Product Description 161

KUR – 113 – Fracture Repair – Product Status 162

KUR – 113 – Fracture Repair – Product Description 162

KUR – 113 – Spinal Fusion – Product Status 162

KUR – 113 – Spinal Fusion – Product Description 163

Kuros Biosciences AG – Ongoing Clinical Trials Overview 164

KUR – 113 – Spinal Fusion – A Prospective, Randomized and Non-randomized, Controlled, Single-blind and Open-label, Dose-finding, Multi-center, Parallel Group Study of Safety/Efficacy of KUR-113 Bone Graft Versus Local Autograft for the Treatment of Single-level Transforaminal Lumbar Interbody Fusion 165

Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 166

MarCell – Product Status 166

MarCell – Product Description 166

MarGraft – Product Status 167

MarGraft – Product Description 167

Locate Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

Chondro3 – Product Status 168

Chondro3 – Product Description 168

CognitOss – Product Status 169

CognitOss – Product Description 169

Ldgraft – Product Status 169

Ldgraft – Product Description 170

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 171

MaxiCure – Product Status 171

MaxiCure – Product Description 171

MaxiSetin – Product Status 172

MaxiSetin – Product Description 172

Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 173

PTMC Bone Forming Filler – Product Status 173

PTMC Bone Forming Filler – Product Description 173

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 174

Amplify rhBMP-2 – Product Status 174

Amplify rhBMP-2 – Product Description 175

GRAFTON ACDF – Product Status 175

GRAFTON ACDF – Product Description 175

INFUSE Bone Graft – PLF – Product Status 176

INFUSE Bone Graft – PLF – Product Description 176

INFUSE Bone Graft – TLIF – Product Status 176

INFUSE Bone Graft – TLIF – Product Description 177

Medtronic Plc – Ongoing Clinical Trials Overview 178

INFUSE Bone Graft – PLF – A Prospective, Randomized, Multi-center, Open-label Pilot Study of Infuse Bone Graft with Mastergraft Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-level Degenerative Lumbosacral Spinal Conditions 179

INFUSE Bone Graft – TLIF – B.O.N.E: BMP Outcomes and New Evidence in TLIF Procedures (TLIF Pilot Dosing Study) 180

MEGA Bio Pharma Pipeline Products & Ongoing Clinical Trials Overview 181

Bionacre – Orthopedic Bone Graft – Product Status 181

Bionacre – Orthopedic Bone Graft – Product Description 181

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 182

Cortical Strut – Product Status 182

Cortical Strut – Product Description 182

N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 183

Antimicrobial Biodegradable Bone Graft – Product Status 183

Antimicrobial Biodegradable Bone Graft – Product Description 183

NanoFUSE Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 184

NanoBEAD D – Product Status 184

NanoBEAD D – Product Description 184

National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 185

Composite Bone Graft Substitute – Product Status 185

Composite Bone Graft Substitute – Product Description 185

National University of Science and Technology MiSiS Pipeline Products & Ongoing Clinical Trials Overview 186

Hybrid Bone Implant – Product Status 186

Hybrid Bone Implant – Product Description 186

Nutech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 187

NuFix SPIF Spinous Process Allograft – Product Status 187

NuFix SPIF Spinous Process Allograft – Product Description 187

NuVasive Inc Pipeline Products & Ongoing Clinical Trials Overview 188

Osteocel XC – Product Status 188

Osteocel XC – Product Description 188

Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 189

CelGro SMRT Graft – Hip Cartilage – Product Status 189

CelGro SMRT Graft – Hip Cartilage – Product Description 189

Celgro SMRT Graft – Rotator-Cuff Tendon Repair – Product Status 190

Celgro SMRT Graft – Rotator-Cuff Tendon Repair – Product Description 190

OrthoMedex LLC Pipeline Products & Ongoing Clinical Trials Overview 191

Cancellous Bone Allograft – Product Status 191

Cancellous Bone Allograft – Product Description 191

Orthosera GmbH Pipeline Products & Ongoing Clinical Trials Overview 192

Antibiotic Bone Graft – Product Status 192

Antibiotic Bone Graft – Product Description 192

OssiFi Inc Pipeline Products & Ongoing Clinical Trials Overview 193

Next Generation OssiFi Bone Graft Substitute – Product Status 193

Next Generation OssiFi Bone Graft Substitute – Product Description 193

OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 194

NovoGro I – Product Status 194

NovoGro I – Product Description 194

Osteopore International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 195

3D Printed Cage – Leg Amputation – Product Status 195

3D Printed Cage – Leg Amputation – Product Description 195

PCL-TCP 3D-Printed Bone Scaffold – Product Status 196

PCL-TCP 3D-Printed Bone Scaffold – Product Description 196

Osteopore International Pte Ltd – Ongoing Clinical Trials Overview 197

PCL-TCP 3D-Printed Bone Scaffold – The BONE-RECON Trial: A Single-arm Feasibility Trial Evaluating the Mpcl-tcp Scaffold System with Corticoperiosteal Tissue Transfer for Reconstruction of Critical Sized Lower Limb Bone Defects 198

Particle3D Pipeline Products & Ongoing Clinical Trials Overview 199

P3D Bone – Product Status 199

P3D Bone – Product Description 199

PolyPid Ltd Pipeline Products & Ongoing Clinical Trials Overview 200

D-Plex1000 – Product Status 200

D-Plex1000 – Product Description 200

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 201

Bone Regeneration Foam – Product Status 201

Bone Regeneration Foam – Product Description 201

Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 202

HAnano Bone – Product Status 202

HAnano Bone – Product Description 202

ReCaPP Pipeline Products & Ongoing Clinical Trials Overview 203

ReCapp Putty – Product Status 203

ReCapp Putty – Product Description 203

RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 204

Bone Graft Substitute – Load Bearing – Product Status 204

Bone Graft Substitute – Load Bearing – Product Description 204

StronBone-P – Product Status 205

StronBone-P – Product Description 205

Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 206

Tendon – ACL Repair – Product Status 206

Tendon – ACL Repair – Product Description 206

Richard L. Roudebush VAMC Pipeline Products & Ongoing Clinical Trials Overview 207

Osteoinductive Porous Graft – Product Status 207

Osteoinductive Porous Graft – Product Description 207

ROKIT Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview 208

Cartilage Regen – Product Status 208

Cartilage Regen – Product Description 208

Femur Head – Product Status 209

Femur Head – Product Description 209

Femur Plate – Product Status 209

Femur Plate – Product Description 210

Tibia Shaft – Product Status 210

Tibia Shaft – Product Description 210

Sanara MedTech Inc Pipeline Products & Ongoing Clinical Trials Overview 211

Bone Void Filler – Product Status 211

Bone Void Filler – Product Description 211

Scil Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 212

ST01 Bone Graft Substitute Material – Product Status 212

ST01 Bone Graft Substitute Material – Product Description 212

SDIP Innovations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 213

JAZBI – Product Status 213

JAZBI – Product Description 213

SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214

Rapid Graft Delivery Device – Product Status 214

Rapid Graft Delivery Device – Product Description 214

Serigen Mediproducts Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 215

Serioss – Product Status 215

Serioss – Product Description 215

SIRAKOSS Ltd Pipeline Products & Ongoing Clinical Trials Overview 216

MaxSi Graft Granules – Product Status 216

MaxSi Graft Granules – Product Description 216

MaxSi Graft Putty – Product Status 217

MaxSi Graft Putty – Product Description 217

Osteo3 ZP Putty – Product Status 217

Osteo3 ZP Putty – Product Description 218

Smith & Nephew Inc Pipeline Products & Ongoing Clinical Trials Overview 219

NovoSorb – Bone Void Filler – Product Status 219

NovoSorb – Bone Void Filler – Product Description 219

Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 220

SeriACL Scaffold – Product Status 220

SeriACL Scaffold – Product Description 220

SeriCuff Scaffold – Product Status 221

SeriCuff Scaffold – Product Description 221

Soteira Inc Pipeline Products & Ongoing Clinical Trials Overview 222

Nanotechnology Bone Biomaterial – Spinal Repair – Product Status 222

Nanotechnology Bone Biomaterial – Spinal Repair – Product Description 222

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 223

Bioceramic Cage – Product Status 223

Bioceramic Cage – Product Description 223

STEL Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 224

Rotator Cuff Graft – Product Status 224

Rotator Cuff Graft – Product Description 224

SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 225

ChondroColl – Product Status 225

ChondroColl – Product Description 225

Surgalign Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 226

CR-Plug – Product Status 226

CR-Plug – Product Description 226

Xenograft Tendon – Product Status 227

Xenograft Tendon – Product Description 227

SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview 228

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft – Product Status 228

OsteoFlo NanoPutty-Quadphasic Synthetic Bone Graft – Product Description 228

T&R Biofab Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 229

TnR huCartilage – Product Status 229

TnR huCartilage – Product Description 229

TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview 230

MENISC-T – Product Status 230

MENISC-T – Product Description 230

PHOENIX DBM – Product Status 231

PHOENIX DBM – Product Description 231

PHOENIX DBM+ – Product Status 231

PHOENIX DBM+ – Product Description 232

The Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 233

Osteoinductive Composite Scaffold – Product Status 233

Osteoinductive Composite Scaffold – Product Description 233

Theragnostic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 234

GraFix – Open Fractures – Product Status 234

GraFix – Open Fractures – Product Description 234

Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 235

TRS Bioactive Implant – Bone Void Filler – Product Status 235

TRS Bioactive Implant – Bone Void Filler – Product Description 235

Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 236

Drug Eluting Porous Scaffold – Product Status 236

Drug Eluting Porous Scaffold – Product Description 236

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 237

Synthetic Bone Graft – Product Status 237

Synthetic Bone Graft – Product Description 237

University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 238

Shapeable Foam – Bone Repair – Product Status 238

Shapeable Foam – Bone Repair – Product Description 238

University of Malaya Pipeline Products & Ongoing Clinical Trials Overview 239

Amniotic Scaffold – Product Status 239

Amniotic Scaffold – Product Description 239

University of Maryland Pipeline Products & Ongoing Clinical Trials Overview 240

Injectable Scaffold – Product Status 240

Injectable Scaffold – Product Description 240

University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 241

Three-Dimensional Bone Tissue Graft – Product Status 241

Three-Dimensional Bone Tissue Graft – Product Description 241

University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 242

Chitosan Guided Bone Regeneration Membrane – Product Status 242

Chitosan Guided Bone Regeneration Membrane – Product Description 242

University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 243

Osteochondral Constructs – Joint Repair – Product Status 243

Osteochondral Constructs – Joint Repair – Product Description 243

University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 244

ChondroGraft – Product Status 244

ChondroGraft – Product Description 244

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 245

Interconnected Porous Material – Product Status 245

Interconnected Porous Material – Product Description 245

UNSW Medicine Pipeline Products & Ongoing Clinical Trials Overview 246

3D-Print Bone – Product Status 246

3D-Print Bone – Product Description 246

Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 247

Bone Graft Extender – Product Status 247

Bone Graft Extender – Product Description 247

Vivex Biologics Inc Pipeline Products & Ongoing Clinical Trials Overview 248

VIA Disc – Product Status 248

VIA Disc – Product Description 248

Vivex Biologics Inc – Ongoing Clinical Trials Overview 249

Figures

Bone Grafts and Substitutes – Pipeline Products by Stage of Development 24

Bone Grafts and Substitutes – Pipeline Products by Segment 25

Bone Grafts and Substitutes – Pipeline Products by Territory 26

Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 27

Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 28

Bone Grafts and Substitutes – Ongoing Clinical Trials 29

Frequently asked questions

Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.